Various social and environmental factors in different locations across the U.S. influenced a decline in lung function among adolescents and…
Articles by Steve Bryson, PhD
The total cost of managing cystic fibrosis (CF) — healthcare costs, patient and caregiver costs, as well as costs…
At-home telemonitoring of lung function in children with cystic fibrosis (CF) can detect the early onset of pulmonary exacerbations,…
Fas, a protein that triggers programmed cell death, was identified as a potential urinary biomarker for kidney injury associated with…
Cough and sputum symptoms in adults with cystic fibrosis (CF), as assessed by the Cough and Sputum Assessment Questionnaire…
Blocking iron-dependent cell death, a process called ferroptosis, may treat antibiotic-resistant Pseudomonas aeruginosa lung infections in people with…
Long-term Trikafta treatment led to sustained improvements in CFTR function and reduced lung symptoms in children, ages 6-11, with…
Sionna Therapeutics’ second-generation molecules, combined with standard CFTR modulators, fully restored the production and function of the CFTR…
A high degree of genetic diversity was found among strains of Pseudomonas aeruginosa bacteria initially infecting the lungs of…
All the cystic fibrosis (CF) patients participating in the Phase 2 portion of a clinical trial have been dosed…